ArriVent BioPharma Inc (AVBP) Stock Price, Quote, News & History

AVBPNASDAQ
$33.19
0.431.31%
At close: Jul 17, 5:00 PM EST
$33.19
N/A
After Hours: Jul 17, 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-134.47M
Investing Cash Flow (TTM)
-104.47M
Financing Cash Flow (TTM)
251.18M
Free Cash Flow (TTM)
-134.47M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
12.24M

Analyst Trends and Forecast

5
Mar
1
Apr
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.22B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.71
Earnings Yield % (TTM)
-10.32%
Earnings Yield % (FWD)
-12.05%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.96

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$62.10M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$32.25
Close
$33.19
Volume / Avg.
839.97K / 540.45K
Day Range
$31.61 - $33.81
52 Wk Range
16.10 - 35.83
Market Cap
$1.55B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
54
Short Interest
17.43%
Days to Cover
9.05

About

Sector
Health Care
Industry
Biotechnology
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on a...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ArriVent BioPharma (AVBP) stock?

A

You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ArriVent BioPharma (AVBP) competitors?

A

There are no as such competitors for ArriVent BioPharma.

Q

What is the forecast, or price target, for ArriVent BioPharma (AVBP) stock?

A

ArriVent BioPharma has a consensus price target of $41.69.

Q

What is the current price for ArriVent BioPharma (AVBP)?

A

The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $33.19 last updated July 17, 2026 at 4:00 PM EDT.

Q

Does ArriVent BioPharma (AVBP) pay a dividend?

A

There are no upcoming dividends for ArriVent BioPharma.

Q

When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?

A

ArriVent BioPharma does not have any upcoming earnings scheduled.

Q

Is ArriVent BioPharma (AVBP) going to split?

A

There is no upcoming split for ArriVent BioPharma.

Q

What sector and industry does ArriVent BioPharma (AVBP) operate in?

A

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.